Showing results (301-310 of 553) with videos related to
Sort By:
Pageof 56
Drugs in Context|March 24, 2025
Real-world experience with brodalumab in a Portuguese cohort of patients with moderate-to-severe psoriasisTiago Torres, Pedro Mendes-Bastos, Joana Antunes, et al.Drugs in Context|September 30, 2024
Clinical remission and control in severe asthma: agreements and disagreementsAnnamaria Bosi, Carlo Lombardi, Cristiano Caruso, et al.Drugs in Context|October 17, 2024
Multidisciplinary and personalized approach to the management of mycosis fungoides with chlormethine gel: a collection of clinical experiencesSilvia Alberti Violetti, Marco Ardigò, Paolo Fava, et al.Drugs in Context|February 28, 2025
Is carvedilol superior to propranolol in patients with cirrhosis with portal hypertension: a systematic and meta-analysisSiddheesh Rajpurohit, Balaji Musunuri, Pooja Basthi Mohan, et al.Drugs in Context|July 29, 2024
Antibiotic-induced neuropsychiatric toxicity: epidemiology, mechanisms and management strategies - a narrative literature reviewAli A Althubyani, Samantha Canto, Huy Pham, et al.Drugs in Context|June 25, 2024
Evaluation of the criteria for renewal of LHRH agonists in patients with prostate cancer: results of the ANAREN StudyJesús Calleja-Escudero, Víctor Barrondo, Andrés Rodriguez-Alonso, et al.Drugs in Context|June 25, 2024
Invasive fungal infections in critically ill children: epidemiology, risk factors and antifungal drugsKam Lun Ellis Hon, Vivian Py Chan, Alexander Kc Leung, et al.Drugs in Context|January 20, 2023
Emerging concepts in heart failure management and treatment: focus on tachycardia-induced cardiomyopathyMaría Victoria Báez Cabanillas, Roberto Colque, Miguel Ángel Tibaldi, et al.Drugs in Context|January 15, 2019
Menopause hormone therapy: latest developments and clinical practiceTomas FaitDrugs in Context|April 27, 2019
Second-line treatment options in hepatocellular carcinomaDonatella Marino, Clizia Zichi, Marco Audisio, et al.Pageof 56